Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

Siu W. Lam; Nienke M. Nota; Agnes Jager; Monique M. E. M. Bos; Joan van den Bosch; Ankie M. T. van der Velden; Johanneke E. A. Portielje; Aafke H. Honkoop; Harm van Tinteren; Epie Boven

doi:https://doi.org/10.1158/1078-0432.CCR-15-1005

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

Siu W. Lam, Nienke M. Nota, Agnes Jager, Monique M. E. M. Bos, Joan van den Bosch, Ankie M. T. van der Velden, Johanneke E. A. Portielje, Aafke H. Honkoop, Harm van Tinteren, Epie Boven

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Original language	English
Pages (from-to)	1611-1620
Journal	Clinical Cancer Research
Volume	22
Issue number	7
DOIs	https://doi.org/10.1158/1078-0432.CCR-15-1005
Publication status	Published - 1 Apr 2016

Access to Document

https://doi.org/10.1158/1078-0432.CCR-15-1005

Cite this

Lam, S. W., Nota, N. M., Jager, A., Bos, M. M. E. M., van den Bosch, J., van der Velden, A. M. T., Portielje, J. E. A., Honkoop, A. H., van Tinteren, H., & Boven, E. (2016). Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy. Clinical Cancer Research, 22(7), 1611-1620. https://doi.org/10.1158/1078-0432.CCR-15-1005

@article{7a2e2360a08c4dd2ba65d059a30b94bb,

title = "Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy",

author = "Lam, {Siu W.} and Nota, {Nienke M.} and Agnes Jager and Bos, {Monique M. E. M.} and {van den Bosch}, Joan and {van der Velden}, {Ankie M. T.} and Portielje, {Johanneke E. A.} and Honkoop, {Aafke H.} and {van Tinteren}, Harm and Epie Boven",

year = "2016",

month = apr,

day = "1",

doi = "https://doi.org/10.1158/1078-0432.CCR-15-1005",

language = "English",

volume = "22",

pages = "1611--1620",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

Lam, SW, Nota, NM, Jager, A, Bos, MMEM, van den Bosch, J, van der Velden, AMT, Portielje, JEA, Honkoop, AH, van Tinteren, H & Boven, E 2016, 'Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy', Clinical Cancer Research, vol. 22, no. 7, pp. 1611-1620. https://doi.org/10.1158/1078-0432.CCR-15-1005

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy. / Lam, Siu W.; Nota, Nienke M.; Jager, Agnes et al.
In: Clinical Cancer Research, Vol. 22, No. 7, 01.04.2016, p. 1611-1620.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

AU - Lam, Siu W.

AU - Nota, Nienke M.

AU - Jager, Agnes

AU - Bos, Monique M. E. M.

AU - van den Bosch, Joan

AU - van der Velden, Ankie M. T.

AU - Portielje, Johanneke E. A.

AU - Honkoop, Aafke H.

AU - van Tinteren, Harm

AU - Boven, Epie

PY - 2016/4/1

Y1 - 2016/4/1

U2 - https://doi.org/10.1158/1078-0432.CCR-15-1005

DO - https://doi.org/10.1158/1078-0432.CCR-15-1005

M3 - Article

C2 - 26823602

SN - 1078-0432

VL - 22

SP - 1611

EP - 1620

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 7

ER -